Selskabets formål er at drive industri-, handels- og investeringsvirksomhed
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 189.8 mio. | -155.4 mio. | 123.9 mio. | -341.8 mio. | 70 | |
CVR: 25384687
Secondary names: Scanning Technology ApS, Otometrics ApS, Alpine Biomed ApS
Previous names: A/S PSE NR. 5600, GN AF 16. JUNI 2000 A/S, GN OTOMETRICS A/S
Companies in the same industry and area
BDO Statsautoriseret Revisionspartnerselskab appointed as auditor
KPMG P/S resigned as auditor
Peter Demuth Lundemann joined the board
Danda Zhao joined the board
Kelly Jean Summers joined the board
Jens Bo Hesselberg Larsen left the board
Douglas Allan Balog left the board
Mary Martha Kennedy left the board
Carsten Gjedahl Kind joined as ADM. DIR.
Mary Martha Kennedy left as ADM. DIR.
Compared to 52 companies in Fremstilling af bestrålingsudstyr og elektromedicinsk og elektroterapeutisk udstyr
Comparison is based on industry median values
Natus Medical Denmark ApS is currently facing significant financial challenges, with a troubling trend of declining equity and persistent losses. In 2024, the company reported revenue of 189.8 million DKK but incurred a loss of 155.4 million DKK, following a similar pattern from previous years where profits have consistently been negative, peaking at a loss of 239.4 million DKK in 2022. The equity position has deteriorated sharply, dropping to -341.8 million DKK in 2024, indicating substantial financial instability. Despite being positioned in the medical equipment manufacturing industry, the company's declining revenue from a high of 382.1 million DKK in 2020 raises concerns about its operational viability and market competitiveness.
AI-generated summary
companydata.dk